Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mcarmel
    Junior Member
    • May 2014
    • 1

    #1

    A mismatch between BAM file and final SNP sequence

    Hi,
    We performed whole exome sequencing for 7 individuals from the same family (parents and 5 children). The company who has done the test used the GATK software.
    In the analysis we looked for unique risk factors variants in the affected children. We found some SNPs that were unique to some of the children and were missing in the parents. In other words, the parents were homozygous for certain SNP (AA) and some of the children were heterozygous for the same SNP (AC). We thought it might be caused by a de novo change.
    In order to check this, we examined the BAM files at the SNP location for the parents and the children and found:
    Mother: number of reads A-73 (76.8%); C-22 (23.2%). The final SNP received by software was AA.
    Father: number of reads A-76 (81.7%); C-17 (18.3%). The final SNP received by software was AA
    Child 1: number of reads A-56 (76.7%); C-17 (23.3%). The final SNP received by software was AC
    Child 2: number of reads A-45 (68.2%); C-21 (31.8%). The final SNP received by software was AA

    I would appreciate if someone can explain to me:
    What are the parameters that affect and determine the final decision of the SNP sequence?
    Why the final SNP sequence is different although the distribution of the reads is the same for all members of the family (especially the mother and child 1)?
    What cause the discrepancy?

    Thank you from a new beginner in this interesting area

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...